{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:14:54Z","timestamp":1761920094332},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00415-015-8018-7","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T06:36:44Z","timestamp":1453703804000},"page":"1274-1279","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Analysis of nocebo effects of antiepileptic drugs across different conditions"],"prefix":"10.1007","volume":"263","author":[{"given":"Gaetano","family":"Zaccara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Sean","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"8018_CR1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/embor.2010.108","volume":"11","author":"R Sullivan","year":"2010","unstructured":"Sullivan R, Behncke I, Purushotham A (2010) Why do we love medicines so much? An evolutionary perspective on the human love of pills, potions and placebo. EMBO Rep 11:572\u2013578","journal-title":"EMBO Rep"},{"key":"8018_CR2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2013.07.009","volume":"140","author":"D Murray","year":"2013","unstructured":"Murray D, Stoessl AJ (2013) Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions. Pharmacol Ther 140:306\u2013318","journal-title":"Pharmacol Ther"},{"key":"8018_CR3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(09)61706-2","volume":"375","author":"DG Finniss","year":"2010","unstructured":"Finniss DG, Kaptchuk TJ, Miller F, Benedetti F (2010) Placebo effects: biological, clinical and ethical advances. Lancet 375:686\u2013695","journal-title":"Lancet"},{"key":"8018_CR4","first-page":"459","volume":"109","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Hansen E, Enck P (2012) Nocebo phenomena in medicine: their relevance in everyday clinical practice. Dtsch Arztebl Int 109:459\u2013465","journal-title":"Dtsch Arztebl Int"},{"key":"8018_CR5","unstructured":"Annoni M (2013) Highlights from the 2013 Science of Placebo thematic workshop. eCancer 7:346"},{"key":"8018_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yebeh.2014.12.004","volume":"43","author":"G Zaccara","year":"2015","unstructured":"Zaccara G, Giovannelli F, Schmidt D (2015) Placebo and nocebo responses in drug trials of epilepsy. Epilepsy Behav 43:128\u2013134","journal-title":"Epilepsy Behav"},{"key":"8018_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pain.2009.07.010","volume":"146","author":"M Amanzio","year":"2009","unstructured":"Amanzio M, Corazzini LL, Vase L, Benedetti F (2009) A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 146:261\u2013269","journal-title":"Pain"},{"key":"8018_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00415-014-7391-y","volume":"262","author":"G Zaccara","year":"2015","unstructured":"Zaccara G, Giovannelli F, Cincotta M, Loiacono G, Verrotti A (2015) Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review. J Neurol 262:501\u2013515","journal-title":"J Neurol"},{"key":"8018_CR9","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097","journal-title":"PLoS Med"},{"key":"8018_CR10","unstructured":"Higgins JPT, Altman DG. (2008) Chapter 8: assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008]. Available at website: http:\/\/www.cochrane-handbook.org\/ . Accessed October 2015"},{"key":"8018_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","volume":"9","author":"BC Wallace","year":"2009","unstructured":"Wallace BC, Schmid CH, Lau J, Trikalinos TA (2009) Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 9:80","journal-title":"BMC Med Res Methodol"},{"key":"8018_CR12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1098\/rstb.2010.0384","volume":"366","author":"P Enck","year":"2011","unstructured":"Enck P, Klosterhalfen S, Weimer K et al (2011) The placebo response in clinical trials: more questions than answers. Philos Trans R Soc 366:1889\u20131895","journal-title":"Philos Trans R Soc"},{"key":"8018_CR13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.psychres.2013.10.019","volume":"215","author":"DD Mitsikostas","year":"2014","unstructured":"Mitsikostas DD, Mantonakis L, Chalarakis N (2014) Nocebo in clinical trials for depression: a meta-analysis. Psychiatry Res 215:82\u201386","journal-title":"Psychiatry Res"},{"key":"8018_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ene.12014","volume":"20","author":"P Stathis","year":"2013","unstructured":"Stathis P, Smpiliris M, Konitsiotis S, Mitsikostas DD (2013) Nocebo as a potential confounding factor in clinical trials for Parkinson\u2019s disease treatment: a meta-analysis. Eur J Neurol 20:527\u2013533","journal-title":"Eur J Neurol"},{"key":"8018_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1129-2377-15-70","volume":"15","author":"XQ Wang","year":"2014","unstructured":"Wang XQ, Lang SY, He MW, Zhang X, Zhu F, Dai W, Shi XB, Wan M, Ma YF, Chen YN, Yu SY (2014) High prevalence of headaches in patients with epilepsy. J Headache Pain 15:70","journal-title":"J Headache Pain"},{"key":"8018_CR16","first-page":"251","volume":"21","author":"KJ Hossain","year":"2012","unstructured":"Hossain KJ, Nandi AK, Karim MR, Haque MM, Kamal MM (2012) Pattern of mental illness on substance abusers. Mymensingh Med J 21:251\u2013258","journal-title":"Mymensingh Med J"},{"key":"8018_CR17","first-page":"927","volume":"11","author":"C Aichm\u00fcller","year":"2015","unstructured":"Aichm\u00fcller C, Soyka M (2015) Fatigue in substance abuse disorders. Rev Med Suisse 11:927\u2013930","journal-title":"Rev Med Suisse"},{"key":"8018_CR18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG (2012) Adverse effects of antiepileptic drugs. Lancet Neurol 11:792\u2013802","journal-title":"Lancet Neurol"},{"key":"8018_CR19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1528-1157.1998.tb01361.x","volume":"39","author":"GA Baker","year":"1998","unstructured":"Baker GA, Camfield C, Camfield P, Cramer JA, Elger CE, Johnson AL, Martins da Silva A, Meinardi H, Munari C, Perucca E, Thorbeke R (1998) Commission on outcome measurement in epilepsy, 1994\u20131997: final report. Epilepsia 39:213\u2013231","journal-title":"Epilepsia"},{"key":"8018_CR20","doi-asserted-by":"crossref","first-page":"h4672","DOI":"10.1136\/bmj.h4672","volume":"351","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P, Greenwood N (2015) Understanding the Hawthorne effect. BMJ 351:h4672","journal-title":"BMJ"},{"key":"8018_CR21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2165\/00023210-200519110-00001","volume":"19","author":"E Perucca","year":"2005","unstructured":"Perucca E, Kwan P (2005) Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs 19:897\u2013908","journal-title":"CNS Drugs"},{"key":"8018_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","volume":"62","author":"FG Gilliam","year":"2004","unstructured":"Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62:23\u201327","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-8018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-8018-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-8018-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:22:59Z","timestamp":1559071379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-8018-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["8018"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-8018-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}